Unknown

Dataset Information

0

Experimental Single-Platform Approach to Enhance the Functionalization of Magnetically Targetable Cells.


ABSTRACT: Magnetic guidance shows promise as a strategy for improving the delivery and performance of cell therapeutics. However, clinical translation of magnetically guided cell therapy requires cell functionalization protocols that provide adequate magnetic properties in balance with unaltered cell viability and biological function. Existing methodologies for characterizing cells functionalized with magnetic nanoparticles (MNP) produce aggregate results, both distorted and unable to reflect variability in either magnetic or biological properties within a preparation. In the present study, we developed an inverted-plate assay allowing determination of these characteristics using a single-platform approach, and applied this method for a comparative analysis of two loading protocols providing highly uniform vs. uneven MNP distribution across cells. MNP uptake patterns remarkably different between the two protocols were first shown by fluorimetry carried out in a well-scan mode on endothelial cells (EC) loaded with BODIPY558/568-labeled MNP. Using the inverted-plate assay we next demonstrated that, in stark contrast to unevenly loaded cells, more than 50% of uniformly functionalized EC were captured within 5 min over a broad range of MNP doses. Furthermore, magnetically captured cells exhibited unaltered viability, substrate attachment, and proliferation rates. Conducted in parallel, magnetophoretic mobility studies corroborated the markedly superior guidance capacity of uniformly functionalized cells, confirming substantially faster cell capture kinetics on a clinically relevant time scale. Taken together, these results emphasize the importance of optimizing cell preparation protocols with regard to loading uniformity as key to efficient site-specific delivery, engraftment, and expansion of the functionalized cells, essential for both improving performance and facilitating translation of targeted cell therapeutics.

SUBMITTER: Battig MR 

PROVIDER: S-EPMC7687866 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6187371 | biostudies-literature
| S-EPMC6874855 | biostudies-literature
| S-EPMC3065496 | biostudies-literature
| S-EPMC4264692 | biostudies-literature
| S-EPMC5392167 | biostudies-literature
| S-EPMC7306589 | biostudies-literature
| S-EPMC7475195 | biostudies-literature
| S-EPMC8160473 | biostudies-literature
| S-EPMC2993077 | biostudies-literature
| S-EPMC6937132 | biostudies-literature